096â Assessment of the efficacy of erenumab during the open-label treatment (13â24 weeks) of subjects with episodic migraine who failed 2â4 prior preventive treatments: results of the LIBERTY study
Giles, Lauren, Reuter, Uwe, Goadsby, Peter, Lanteri-Minet, Michel, Hours-Zesiger, Peggy, Fernandes, Chrystel, Ferrari, Michel, Klatt, JanVolume:
90
Journal:
Journal of Neurology, Neurosurgery & Psychiatry
DOI:
10.1136/jnnp-2019-anzan.84
Date:
July, 2019
File:
PDF, 49 KB
2019